Israeli drug could successfully treat flesh-eating bacteria
The drug is undergoing a Phase Three clinical trial this year and if all goes as planned, the life saving drug could be available by 2020.
Dan Teleman, the CEO of Israeli pharmaceutical start-up Atox Bio, is helping to prepare one of the first drug treatments for flesh-eating bacteria.(photo credit: Courtesy)ByMAX SCHINDLERUpdated:
